FBRX CIK: 1419041

Forte Biosciences, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.5
FY22:
−13.9
FY23:
−32.5
FY24:
−36.6
FY25:
−70.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.5
FY22:
−13.9
FY23:
−32.5
FY24:
−36.6
FY25:
−70.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.7
FY22:
−13.9
FY23:
−31.5
FY24:
−35.5
FY25:
−68.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.7
FY22:
−13.9
FY23:
−31.5
FY24:
−35.5
FY25:
−69.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data